Stryker (NYSE:SYK) - Aktienkurs, Nachrichten und Analyse

SYK Aktienübersicht

Die Stryker Corporation ist ein Unternehmen der Medizintechnik.

SYK grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	1/6
Künftiges Wachstum	2/6
Vergangene Leistung	5/6
Finanzielle Gesundheit	4/6
Dividenden	4/6

Belohnungen

Prognostiziertes Gewinnwachstum 10.53% pro Jahr

Die Erträge stiegen im vergangenen Jahr um 27.9%

Risikoanalyse

Signifikante Insiderverkäufe in den letzten 3 Monaten

Hat einen hohen Schuldenstand

Community Narratives

Narratives bring a range of perspectives from our community.

WarrenAI

Based on Analyst Price Targets

Elevating Future Success Through Organic Growth, Calculated Acquisitions, And Innovation

US$372.75

3.3% undervalued

7.83%

Revenue growth p.a.

about 1 month ago

Tokyo

Community Contributor

Investing in Stryker (SYK) should be an easy ride

US$323.52

11.4% overvalued

6.00%

Revenue growth p.a.

about 2 months ago

Stryker Corporation Wettbewerber

Boston Scientific

NYSE:BSX

US$120.4b

Intuitive Surgical

NasdaqGS:ISRG

US$175.1b

Medtronic

NYSE:MDT

US$113.6b

Abbott Laboratories

NYSE:ABT

US$197.1b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Stryker
Historische Aktienkurse
Aktueller Aktienkurs	US$360.42
52-Wochen-Hoch	US$361.41
52-Wochen-Tief	US$249.98
Beta	0.90
11 Monat Veränderung	8.70%
3 Monate Veränderung	5.39%
1 Jahr Veränderung	26.71%
33 Jahre Veränderung	30.28%
5 Jahre Veränderung	65.95%
Veränderung seit IPO	66,439.04%

Aktuelle Nachrichten und Updates

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Sep 01

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Aug 21

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Aug 10

Recent updates

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Sep 01

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Aug 21

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 02

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Apr 29

Stryker: A Great Company At An Expensive Price

Apr 05

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Mar 26

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Mar 25

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

Mar 14

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Feb 21

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Feb 10

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Feb 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Jan 24

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Jan 02

Stryker: Mako Shoulder And Spine Launches Are On The Way

Dec 31

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 22

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 08

Why Stryker Is An Awesome Healthcare Compounder

Nov 30

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Nov 10

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Oct 19

Stryker: Don't Buy This Dividend Champion (Yet)

Oct 13

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Oct 08

Is Stryker (NYSE:SYK) A Risky Investment?

Sep 26

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Aug 22

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Jul 18

Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

Jul 06

These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well

Jun 17

Stryker: Good Prospects

Jun 14

With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case

May 24

Should You Think About Buying Stryker Corporation (NYSE:SYK) Now?

May 01

Aktionärsrenditen

	SYK	US Medical Equipment	US Markt
7D	1.7%	1.3%	0.5%
1Y	26.7%	12.1%	22.7%

Rendite im Vergleich zur Industrie: SYK übertraf die Branche US Medical Equipment , die im vergangenen Jahr eine Rendite von -1 erzielte.

Rendite vs. Markt: SYK übertraf den Markt US, der im vergangenen Jahr eine Rendite von 22.9 erzielte.

Preisvolatilität

Is SYK's price volatile compared to industry and market?
SYK volatility
SYK Average Weekly Movement	2.9%
Medical Equipment Industry Average Movement	8.7%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.0%
10% least volatile stocks in US Market	3.1%

Stabiler Aktienkurs: SYK hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: SYKDie wöchentliche Volatilität (2%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1941	52,000	Kevin Lobo	www.stryker.com

Die Stryker Corporation ist als Medizintechnikunternehmen tätig. Das Unternehmen ist in zwei Segmenten tätig: MedSurg und Neurotechnologie sowie Orthopädie und Wirbelsäule. Das Segment Orthopädie und Wirbelsäule bietet Implantate für den totalen Gelenkersatz, z. B. für Hüfte, Knie und Schulter, sowie für Trauma- und Extremitätenoperationen.

Stryker Corporation's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Stryker im Vergleich zum Marktanteil des Unternehmens?
SYK grundlegende Statistiken
Marktanteil	US$137.35b
Gewinn(TTM)	US$3.45b
Umsatz(TTM)	US$21.39b

39.8x

Kurs-Gewinn-Verhältnis

6.4x

Kurs-Umsatz-Verhältnis

Ist SYK zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
SYK Gewinn- und Verlustrechnung (TTM)
Einnahmen	US$21.39b
Kosten der Einnahmen	US$7.70b
Bruttogewinn	US$13.69b
Sonstige Ausgaben	US$10.24b
Umsatz	US$3.45b

Zuletzt gemeldete Gewinne

Jun 30, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	9.05
Bruttomarge	64.00%
Nettogewinnspanne	16.12%
Schulden/Eigenkapital-Verhältnis	61.8%

Wie hat sich SYK auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

0.9%

Aktuelle Dividendenrendite

35%

Ausschüttungsquote

Zahlt SYK eine zuverlässige Dividende?

Siehe SYK Dividendenhistorie und Benchmarks

Bis wann müssen Sie SYK kaufen, um eine kommende Dividende zu erhalten?
Stryker Dividendentermine
Ex-Dividenden Datum	Sep 30 2024
Datum der Dividendenzahlung	Oct 31 2024
Tage bis Ex-Dividende	28 days
Tage bis zum Datum der Dividendenzahlung	59 days

Zahlt SYK eine zuverlässige Dividende?

Siehe SYK Dividendenhistorie und Benchmarks

SYK Aktienübersicht

Belohnungen

Risikoanalyse

Elevating Future Success Through Organic Growth, Calculated Acquisitions, And Innovation

Investing in Stryker (SYK) should be an easy ride

Stryker Corporation Wettbewerber

NYSE:BSX

US$120.4b

NasdaqGS:ISRG

US$175.1b

NYSE:MDT

US$113.6b

NYSE:ABT

US$197.1b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Stryker Corporation (NYSE:SYK) entered into a definitive agreement to acquire Vertos Medical Inc.

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Stryker Corporation (NYSE:SYK) agreed to acquire Care.ai inc.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Second quarter dividend of US$0.80 announced

Recent updates

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Stryker Corporation (NYSE:SYK) entered into a definitive agreement to acquire Vertos Medical Inc.

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Stryker Corporation (NYSE:SYK) agreed to acquire Care.ai inc.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Second quarter dividend of US$0.80 announced

Independent Director notifies of intention to sell stock

Stryker Announces Launch of Pangea Plating System

Stryker: Wait For A Better Entry Point Post-Q2 Results

VP & CFO recently sold US$6.7m worth of stock

Stryker's Spine Guidance 5 Software Featuring Copilot Receives 510(K) Clearance from FDA

Second quarter 2024 earnings: EPS misses analyst expectations

Stryker Corporation (NYSE:SYK) completed the acquisition of Artelon, Inc.

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

VP & CFO exercised options and sold US$3.7m worth of stock

Stryker Corporation to Report Q2, 2024 Results on Jul 30, 2024

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

The Returns At Stryker (NYSE:SYK) Aren't Growing

Stryker Releases Lifepak 35 Monitor/Defibrillator

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) agreed to acquire Artelon, Inc.

Stryker: Margin Gains Should Drive Upside

First European Announces That Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

VP & CFO recently sold US$3.3m worth of stock

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

First quarter dividend of US$0.80 announced

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker: A Great Company At An Expensive Price

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

VP & Chief Accounting Officer notifies of intention to sell stock

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Fourth quarter dividend of US$0.80 announced

New minor risk - Insider selling

Independent Director recently sold US$100m worth of stock

Independent Director notifies of intention to sell stock

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

VP & CFO exercised options and sold US$8.3m worth of stock

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Insufficient new directors

Stryker: Mako Shoulder And Spine Launches Are On The Way

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Erträge & Einnahmen